Quantcast

Latest Genetic testing Stories

2014-07-07 04:20:59

COPENHAGEN, July 7, 2014 /PRNewswire/ -- BGI Diagnostics' NIFTY(TM) test becomes First NIPT based on Next Generation Sequencing Technology to be Approved by the China Food and Drug Administration (CFDA). On June 30, 2014, the CFDA approved the registration of BGI's BGISEQ-1000 and BGISEQ-100 sequencers, and its prenatal genetic testing kits for NIFTY(TM) (Non-Invasive Fetal Trisomy test). This is the first genetic test based on next generation sequencing technology to...

2014-06-30 23:10:07

Hayes, Inc. experts demonstrate how to apply information to create defensible coverage policies. Lansdale, PA (PRWEB) June 30, 2014 Reviewing the medical need for genetic tests and writing coverage policies for these complex assays and conditions can be a daunting task. Creating defensible coverage policies becomes more challenging when the evidence is limited and inconclusive. Translating Limited and Inconclusive Evidence about Genetic Tests into Coverage Policy, a webinar hosted by...

2014-06-25 23:14:27

AllMed webinar provides in-depth review of the latest in standard of care for the genetic testing of breast and ovarian cancer. Portland, Oregon (PRWEB) June 25, 2014 Advances in genetic testing technology have improved detection rates for BRCA1 and BRCA2 mutations in individuals who are at high risk for breast and ovarian cancer, but some mutations are missed with standard genetic testing. During a recent AllMed webinar, Dr. Della Howell, board-certified hematologist-oncologist,...

2014-06-24 23:05:08

GIA announces the release of a comprehensive global report on Genetic Testing markets. Global market for Genetic Testing is forecast to reach US$7.3 billion by 2020, driven by growing healthcare awareness, growing interest in genetic testing for accurate disease diagnosis and treatment decision-making, and favorable reimbursement coverage policies. San Jose, California (PRWEB) June 24, 2014 Follow us on LinkedIn – Almost every known disease, ranging from common maladies to...

2014-06-24 12:27:50

ST. PETERSBURG, Fla., June 24, 2014 /PRNewswire-USNewswire/ -- InformedDNA announced today a strategic new collaboration with Edimer Pharmaceuticals to address a critical research need for patients with X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), a rare genetic disorder. The partnership will allow InformedDNA to identify patients with XLHED and support Edimer's clinical programs. Under the agreement, InformedDNA has developed a genetic counseling program for patients and...

2014-06-24 10:57:10

University of Oxford Computer analysis of photographs could help doctors diagnose which condition a child with a rare genetic disorder has, say Oxford University researchers. The researchers, funded in part by the Medical Research Council (MRC), have come up with a computer programme that recognises facial features in photographs; looks for similarities with facial structures for various conditions, such as Down's syndrome, Angelman syndrome, or Progeria; and returns possible matches...

2014-06-17 12:29:04

ST. PETERSBURG, Fla., June 17, 2014 /PRNewswire-USNewswire/ -- InformedDNA announced today the appointment of Duffy Oelberg as the Senior Vice President for Business Development. Oelberg will be responsible for the development and implementation of the company's strategy for identifying and capitalizing on new opportunities to expand its portfolio of clients. Oelberg will also serve on InformedDNA's executive leadership team that is responsible for managing all company operations....

2014-06-16 09:36:11

Moffitt Cancer Center A new Moffitt Cancer Center study published Thursday in Genetics in Medicine shows that counseling from a genetic health care provider before genetic testing educates patients and may help reduce unnecessary procedures. Up to 10 percent of cancers are inherited, meaning a person was born with an abnormal gene that increases their risk for cancer.  “Pre-test genetic counseling in which a health care provider takes a thorough family history and discusses the...

2014-06-15 23:00:59

MarketReportsOnline.com adds "US Prenatal Testing Market Report: 2012 Edition" report to its research store. Dallas, Texas (PRWEB) June 15, 2014 This report provides a comprehensive overview of the US prenatal testing market covering the market opportunity for the T21 tests. The prenatal testing realm is getting intensely competitive with numerous corporations claiming the reins of the same. The leading industry players include PerkinElmer, Hologic and Sequenom among other...

2014-06-12 08:30:01

DUBLIN, June 12, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/j73xhs/prenatal_and) has announced the addition of the "Prenatal and New-born Genetic Testing Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Prenatal testing and diagnosis have enabled the detection of certain genetic abnormalities in as early as 8 to 10 weeks of gestation...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related